InvestorsHub Logo
Followers 26
Posts 5775
Boards Moderated 1
Alias Born 08/09/2000

Re: None

Thursday, 01/14/2010 9:19:11 AM

Thursday, January 14, 2010 9:19:11 AM

Post# of 30565
NEWS --

DANVILLE, CA, Jan 14, 2010 (MARKETWIRE via COMTEX) -- S3 Investment Company,
Inc. (PINKSHE ETS: SIVC) today commented on another new contract announced by
Boyuan Construction Group, Inc., a client of its wholly owned Redwood Capital
subsidiary, which successfully completed its entry into the North American
capital markets in March of 2009. Boyuan Construction Group, Inc., which is
publicly traded on Canada's TSX Venture Exchange under the symbol BOY, recently
reported that it had been awarded a contract valued at $19 million to develop a
16-story, 40,000 square meter commercial building in the city of Qingzhou,
located in China's Shandong province.

The project, which is expected to be completed in March 2011, will result in one
of the largest commercial buildings ever to be developed in Qingzhou.

Redwood Capital acted as the Chinese merchant banking advisor for the Boyuan
Construction Group in a reverse takeover transaction which resulted in the
company being listed on the TSX Venture Exchange. As a result of its
part icipation, Redwood Capital received shares of Boyuan common stock. As of the
period ended September 30, 2009, the last reported by the company's financial
disclosure through the Pink Sheets OTC Disclosure and News Service, Redwood
Capital owned 691,203 Boyuan common shares.

Boyuan Construction Group, Inc., a fast-growing construction company in China of
commercial, residential and municipal infrastructure projects, has reported
increased revenues over the previous year in each of the quarters reported since
the company became listed in North America.

"Due to our Boyuan Construction common stock position, we will continue to
follow this company as it signs new contracts and expands its business in the
China market," said S3 Chairman and CEO Jim Bickel. "The value of the Boyuan
shares, in addition to that of other current and future Redwood Capital clients,
forms the basis of the asset value that S3 is building for its shareholders.< BR>While many companies are searching for markets and customers for their services,
Redwood Capital is firmly entrenched in China's robust business landscape."

"The Redwood Capital business model has proven successful in assembling the
assets the company currently holds, and we expect that 2010 will bring
additional stock and stock value as other client listing and funding
transactions are closed," Mr. Bickel added.

To sign up to receive information by email directly from S3 Investment Company
when new press releases, investor newsletters, SEC filings or other information
is disclosed, please visit http://www.s3investments.com/investors/.

About S3 Investment Company, Inc.

S3 Investment Company, Inc. (http://www.s3investments.com) and its Redwood Group
International subsidiary are focused on facilitating the success of two
subsidiaries operating in the China market. Redwood Capital, Inc. assists
private Chinese companies in accessing the North American capital markets by
utilizing a network of investment banking relationships to achieve reverse
merger transactions. For more information, please visit
http://www.redwoodcapinc.com. Redwood Medical, Inc. assists companies seeking to
import and distribute Western medical technologies and products into the China
market.

Any statements contained herein related to future events are forward-looking
statements and are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Readers are cautioned not to place
undue reliance on forward-looking statements. S3 Investment Company, Inc.
undertakes no obligation to update any such statements to reflect actual events.





Contacts

For S3 Investment Company

Gemini Financial Communications, Inc.

951-200-4107

Email Contact





SOURCE: S3 Investment Company




CONTACT: http://www2.marketwire.com/mw/emailprcntct?id=6B5B7C248F5328D4




Copyright 2010 Marketwire, Inc., All rights reserved.

-0-




SUBJECT CODE: Financial Services:Commercial and Investment Banking

Pharmaceuticals and Biotech:Equipment and Supplies

Financial Services:Venture Capital